2,4,9,19-tetrazapentacyclo[10.7.0.02,6.07,11.013,18]nonadeca-1(12),3,5,7(11),13,15,17-heptaene-8,10-dione
| Internal ID | ed7bad5f-05ad-4ce1-b82a-a0ef63f454b3 |
| Taxonomy | Organoheterocyclic compounds > Indoles and derivatives > Pyridoindoles > Alpha carbolines |
| IUPAC Name | 2,4,9,19-tetrazapentacyclo[10.7.0.02,6.07,11.013,18]nonadeca-1(12),3,5,7(11),13,15,17-heptaene-8,10-dione |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C15H8N4O2/c20-14-11-9-5-16-6-19(9)13-10(12(11)15(21)18-14)7-3-1-2-4-8(7)17-13/h1-6,17H,(H,18,20,21) |
| InChI Key | WXUJAQBSBZLVEV-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C15H8N4O2 |
| Molecular Weight | 276.25 g/mol |
| Exact Mass | 276.06472551 g/mol |
| Topological Polar Surface Area (TPSA) | 79.30 Ų |
| XlogP | 2.40 |
| Atomic LogP (AlogP) | 1.85 |
| H-Bond Acceptor | 4 |
| H-Bond Donor | 2 |
| Rotatable Bonds | 0 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9947 | 99.47% |
| Caco-2 | + | 0.7304 | 73.04% |
| Blood Brain Barrier | + | 0.8500 | 85.00% |
| Human oral bioavailability | + | 0.5571 | 55.71% |
| Subcellular localzation | Mitochondria | 0.7177 | 71.77% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.9142 | 91.42% |
| OATP1B3 inhibitior | + | 0.9502 | 95.02% |
| MATE1 inhibitior | - | 0.9800 | 98.00% |
| OCT2 inhibitior | - | 0.8316 | 83.16% |
| BSEP inhibitior | + | 0.6427 | 64.27% |
| P-glycoprotein inhibitior | - | 0.8928 | 89.28% |
| P-glycoprotein substrate | - | 0.8658 | 86.58% |
| CYP3A4 substrate | + | 0.5758 | 57.58% |
| CYP2C9 substrate | + | 0.5848 | 58.48% |
| CYP2D6 substrate | - | 0.8845 | 88.45% |
| CYP3A4 inhibition | - | 0.9253 | 92.53% |
| CYP2C9 inhibition | - | 0.8534 | 85.34% |
| CYP2C19 inhibition | - | 0.7974 | 79.74% |
| CYP2D6 inhibition | - | 0.8315 | 83.15% |
| CYP1A2 inhibition | + | 0.7395 | 73.95% |
| CYP2C8 inhibition | + | 0.4620 | 46.20% |
| CYP inhibitory promiscuity | - | 0.9141 | 91.41% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.9500 | 95.00% |
| Carcinogenicity (trinary) | Non-required | 0.5412 | 54.12% |
| Eye corrosion | - | 0.9839 | 98.39% |
| Eye irritation | - | 0.9639 | 96.39% |
| Skin irritation | - | 0.8774 | 87.74% |
| Skin corrosion | - | 0.9698 | 96.98% |
| Ames mutagenesis | + | 0.7036 | 70.36% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.6654 | 66.54% |
| Micronuclear | + | 0.9300 | 93.00% |
| Hepatotoxicity | + | 0.6659 | 66.59% |
| skin sensitisation | - | 0.9587 | 95.87% |
| Respiratory toxicity | + | 0.7111 | 71.11% |
| Reproductive toxicity | + | 0.6556 | 65.56% |
| Mitochondrial toxicity | + | 0.6250 | 62.50% |
| Nephrotoxicity | + | 0.5213 | 52.13% |
| Acute Oral Toxicity (c) | III | 0.3685 | 36.85% |
| Estrogen receptor binding | + | 0.7906 | 79.06% |
| Androgen receptor binding | + | 0.6321 | 63.21% |
| Thyroid receptor binding | + | 0.6477 | 64.77% |
| Glucocorticoid receptor binding | + | 0.9234 | 92.34% |
| Aromatase binding | + | 0.8442 | 84.42% |
| PPAR gamma | + | 0.8210 | 82.10% |
| Honey bee toxicity | - | 0.8892 | 88.92% |
| Biodegradation | - | 0.9250 | 92.50% |
| Crustacea aquatic toxicity | + | 0.6900 | 69.00% |
| Fish aquatic toxicity | - | 0.7240 | 72.40% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| CHEMBL5785 | P19525 | Interferon-induced, double-stranded RNA-activated protein kinase |
100 nM |
IC50 |
via Super-PRED
|
| CHEMBL4630 | O14757 | Serine/threonine-protein kinase Chk1 |
100 nM |
IC50 |
via Super-PRED
|
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 97.41% | 94.45% |
| CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 94.63% | 93.99% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 93.11% | 88.56% |
| CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 | 92.96% | 94.62% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 92.25% | 94.75% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 92.25% | 95.56% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 90.66% | 98.59% |
| CHEMBL1829 | O15379 | Histone deacetylase 3 | 90.32% | 95.00% |
| CHEMBL1781 | P11387 | DNA topoisomerase I | 89.28% | 97.00% |
| CHEMBL2094121 | P14867 | GABA-A receptor; alpha-1/beta-3/gamma-2 | 89.16% | 95.50% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 88.51% | 94.00% |
| CHEMBL240 | Q12809 | HERG | 88.38% | 89.76% |
| CHEMBL2292 | Q13627 | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | 88.14% | 93.24% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 88.04% | 90.08% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 87.59% | 91.11% |
| CHEMBL308 | P06493 | Cyclin-dependent kinase 1 | 87.49% | 91.73% |
| CHEMBL2716 | Q8WUI4 | Histone deacetylase 7 | 87.34% | 89.44% |
| CHEMBL4225 | P49760 | Dual specificity protein kinase CLK2 | 85.52% | 80.96% |
| CHEMBL5491 | P30291 | Serine/threonine-protein kinase WEE1 | 85.27% | 97.46% |
| CHEMBL2424504 | P29375 | Lysine-specific demethylase 5A | 85.11% | 99.23% |
| CHEMBL1821 | P08173 | Muscarinic acetylcholine receptor M4 | 84.77% | 94.08% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 84.73% | 89.00% |
| CHEMBL2378 | P30307 | Dual specificity phosphatase Cdc25C | 84.69% | 96.67% |
| CHEMBL4145 | Q9UKV0 | Histone deacetylase 9 | 84.40% | 85.49% |
| CHEMBL2708 | Q16584 | Mitogen-activated protein kinase kinase kinase 11 | 83.91% | 81.14% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 83.67% | 92.97% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 83.56% | 99.23% |
| CHEMBL2581 | P07339 | Cathepsin D | 83.33% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 83.05% | 96.09% |
| CHEMBL3401 | O75469 | Pregnane X receptor | 82.78% | 94.73% |
| CHEMBL1868 | P17948 | Vascular endothelial growth factor receptor 1 | 82.61% | 96.47% |
| CHEMBL2095172 | P14867 | GABA-A receptor; alpha-1/beta-2/gamma-2 | 82.35% | 92.67% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 82.01% | 92.29% |
| CHEMBL216 | P11229 | Muscarinic acetylcholine receptor M1 | 81.69% | 94.23% |
| CHEMBL2265 | P23141 | Acyl coenzyme A:cholesterol acyltransferase | 80.23% | 85.94% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 80.11% | 95.56% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 6419741 |
| LOTUS | LTS0047520 |
| wikiData | Q82235793 |